Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Overweight on AlloVir, Raises Price Target to $225

Morgan Stanley maintains AlloVir (NASDAQ:ALVR) with a Overweight and raises the price target from $175 to $225.

byvishwanath@benzinga.com

September 29, 2021

1 minute read

Morgan Stanley maintains AlloVir (NASDAQ:ALVR) with a Overweight and raises the price target from $175 to $225.

Morgan Stanley Maintains Equal-Weight on ONE Gas, Lowers Price Target to $69

By Benzinga Newsdesk

February 22, 1:16 PM

Morgan Stanley analyst Stephen Byrd maintains ONE Gas (NYSE:OGS) with a Equal-Weight and lowers the price target from $72 to $69.

OGS

Roth Capital Downgrades FuboTV to Neutral, Lowers Price Target to $4.25

By Benzinga Newsdesk

May 6, 5:30 AM

Roth Capital analyst Darren Aftahi downgrades FuboTV (NYSE:FUBO) from Buy to Neutral and lowers the price target from $7.5 to $4.25.

FUBO

Brunswick Q3 Adj. EPS $2.07 Beats $1.95 Estimate, Sales $1.43B Beat $1.42B Estimate

By Bill Haddad

October 28, 6:19 AM

Brunswick (NYSE:BC) reported quarterly earnings of $2.07 per share which beat the analyst consensus estimate of $1.95 by 6.15 percent. This is a 15 percent increase over earnings of $1.80 per share from the same period

DallasNews Q4 Adj. Operating Income $300K, Sales $40.60M Down From $40.80M YoY

By Benzinga Newsdesk

March 7, 6:03 PM

DallasNews (NASDAQ:DALN) reported $40.60 million in sales this quarter. This is a 0.49 percent decrease over sales of $40.80 million the same period last year.

DALN

Morgan Stanley Maintains Overweight on AlloVir, Raises Price Target to $225

Related Posts

Morgan Stanley Maintains Equal-Weight on ONE Gas, Lowers Price Target to $69

Roth Capital Downgrades FuboTV to Neutral, Lowers Price Target to $4.25

Brunswick Q3 Adj. EPS $2.07 Beats $1.95 Estimate, Sales $1.43B Beat $1.42B Estimate

DallasNews Q4 Adj. Operating Income $300K, Sales $40.60M Down From $40.80M YoY